Pharmacokinetics of cytosine arabinoside in cerebrospinal fluid and of its metabolite in leukemic cells
✍ Scribed by Békássy, Albert N. ;Liliemark, Jan ;Garwicz, Stanislaw ;Wiebe, Thomas ;Gulliksson, Hans ;Peterson, Curt
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 640 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Concentrations of ara‐CTP in leukemic cells isolated from CSF and of ara‐C in lumbar CSF were measured following intraventricular ara‐C administration in two girls with refractory meningeal leukemia. CSF samples were collected with a permanent intrathecal‐lumbar catheter. In contrast to the comparatively short retention of ara‐C in the CSF (t1/2 1.8 to 2.9 hours), there was a high accumulation and an extremely long retention of ara‐CTP in the leukemic cells (t1/2 8.1 to 36 hours). The patients included in this study had an ara‐C‐resistant disease. No obvious relationship was seen between concentrations of ara‐C in the CSF and of ara‐CTP in the leukemic cells. Similar studies were performed after simultaneous intraventricular administration of hydrocortison and ara‐C. Hydrocortison did not increase ara‐CTP retention in the leukemic cells, nor did it effect CSF pleocytosis.
📜 SIMILAR VOLUMES
Subcutaneous bolus administration of cytosine arabinoside (Ara-C) has been used as an alternative to continuous intravenous infusion. However, the pharmacokinetics of subcutaneous bolus Ara-C have not been satisfactorily documented in man. The plasma concentrations of Ara-C were therefore compared f
The pharmacokinetics of vinpocetine (ethyl apovincaminate, Cavinton) and its metabolite, apovincaminic acid, was studied in patients with cerebrovascular disorders. Vinpocetine (1 mg/kg) was infused intravenously over 25 min. The elimination half-life of the parent drug in plasma was 4.7k2.13 h. Tot
The concentrations of chlorpromazine and some of its metabolites in blood plasma and CSF from chlorpromazine-treated schizophrenics with different therapeutic results were studied. Compared to a good responder a poor responder showed very high levels of the inactive metabolite chlorpromazine sulphox